Another BCL2 family anti-apoptotic member, BCL-w, has been shown to be overexpressed in ~90% of DLBCL (60% with high expression) and BCL-w overexpression was associated with poor prognosis (45, 46). Here, BCL2 is linked to diffuse large B-cell lymphoma.